Survival outcomes for postoperative chemoradiation in intermediate-risk oral tongue cancers.

Michael T SpiottoGina D JeffersonBarry WenigMichael R MarkiewiczRalph R WeichselbaumMatthew Koshy

Published in: Head & neck (2017)

Undergoing S+CRT was associated with improved survival for patients with tongue cancers with ≥2 MLNs and/or pT3-pT4 suggesting that specific intermediate-risk pathological features benefit from treatment intensification.

Keyphrases

rectal cancer
heart failure
left ventricular
atrial fibrillation
replacement therapy